Fundraising FoxTensorbio
2 known investors
Find your way into Tensorbio
Tensor Bio develops a non-invasive, blood-based test that uses cell-free DNA methylation profiling and machine learning to stage liver fibrosis from a single blood draw. It targets MASH/MASLD diagnosis and monitoring, serving hepatologists, primary care clinicians, and biopharma partners who need to identify patients eligible for approved fibrosis therapies.
Investors · 2
Frequently asked questions
- What does Tensorbio do?
- Tensor Bio develops a non-invasive, blood-based test that uses cell-free DNA methylation profiling and machine learning to stage liver fibrosis from a single blood draw. It targets MASH/MASLD diagnosis and monitoring, serving hepatologists, primary care clinicians, and biopharma partners who need to identify patients eligible for approved fibrosis therapies.
- Who are Tensorbio's investors?
- Tensorbio's investors include Convergent Ventures, Initiate Venture Partners.